{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:04:02Z","timestamp":1782302642361,"version":"3.54.5"},"reference-count":39,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2010,2,11]],"date-time":"2010-02-11T00:00:00Z","timestamp":1265846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Immunoglobulin A (IgA)\u2010deficient patients with antibodies to IgA require transfusions with IgA\u2010deficient blood components to either avoid or reduce the frequency of serious adverse reactions. To supply compatible blood components for these individuals, the Canadian Blood Services (CBS) National Testing Laboratory must initially screen and subsequently identify, after confirmatory testing at the American Red Cross (ARC), donors severely deficient in IgA (&lt;0.05\u2003mg\/dL).<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> The Ouchterlony double immunodiffusion assay was used as an initial screen at CBS to identify IgA\u2010deficient donors (test sensitivity 2\u20104\u2003mg\/dL). Sample aliquots from these donors were then sent to the ARC for confirmatory testing using an enzyme\u2010linked immunosorbent assay method for severe IgA deficiency (&lt;0.05\u2003mg\/dL) and a passive hemagglutination assay to detect anti\u2010IgA.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> From November 2007 to December 2008, of 54,594 samples screened initially at CBS there were 137 samples (0.251%) identified as possibly IgA deficient. Of these 137, there were 100 reports returned from ARC confirming severe IgA deficiency in 65 donors (25 female, 40 male) without detectable anti\u2010IgA and in 35 donors (18 female, 17 male) with anti\u2010IgA. The remaining 37 donors had IgA levels of more than 0.05\u2003mg\/dL.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> Results from the ARC confirmed a frequency of 1 in 546 in the CBS' blood donor population for severe IgA deficiency (&lt;0.05\u2003mg\/dL), 1 in 840 for those without anti\u2010IgA, and 1 in 1560 for those with antibody. Donors repeatedly confirmed as severely IgA deficient without anti\u2010IgA were considered eligible for the CBS IgA\u2010deficient donor registry program.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2010.02588.x","type":"journal-article","created":{"date-parts":[[2010,2,11]],"date-time":"2010-02-11T16:58:00Z","timestamp":1265907480000},"page":"1524-1531","source":"Crossref","is-referenced-by-count":30,"title":["Screening of Canadian Blood Services donors for severe immunoglobulin A deficiency"],"prefix":"10.1111","volume":"50","author":[{"given":"Douglas S.","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"O'Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Montreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Scalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi\u2010Long","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Towns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,7]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1984.tb01562.x"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1985.tb00151.x"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1991.31791368341.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.21307\/immunohematology-2019-454"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.01037.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1258\/000456307780117993"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01781.x"},{"key":"e_1_2_8_9_2","first-page":"838","article-title":"Healthy blood donors with selective absence of immunoglobulin A: prevention of anaphylactic transfusion reactions caused by antibodies to IgA","volume":"85","author":"Vyas GN","year":"1975","journal-title":"J Lab Clin Med"},{"key":"e_1_2_8_10_2","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V84.6.2031.2031","article-title":"Hemagglutination assays for the diagnosis and prevention of IgA anaphylactic transfusion reactions","volume":"84","author":"Sandler SG","year":"1994","journal-title":"Blood"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000273347"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.30.11.1007"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(93)90239-4"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33693296811.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1975.tb00495.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood.V90.2.893","article-title":"Prevalence of selective IgG deficiency in Spain: more than we thought","volume":"90","author":"Pereira LF","year":"1997","journal-title":"Blood"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/80.2.210"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1980.tb04091.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000024438"},{"key":"e_1_2_8_20_2","first-page":"157","article-title":"Selective immunoglobulin a deficiency in Iranian blood donors: prevalence, laboratory and clinical findings","volume":"7","author":"Saghafi S","year":"2008","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0955-3886(89)90022-2"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(82)90059-X"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1973.tb03545.x"},{"key":"e_1_2_8_24_2","first-page":"87","article-title":"Frequency of IgA deficiency in blood donors and Rh negative women in Iceland","volume":"85","author":"Gudmundsson S","year":"1977","journal-title":"Acta Pathol Microbiol Scand"},{"key":"e_1_2_8_25_2","first-page":"229","article-title":"Family studies in individuals with selective absence of \u03b3A\u2010globulin","volume":"8","author":"Natvig JB","year":"1971","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_8_26_2","first-page":"330","article-title":"Prevalence of IgA deficiency in Greek blood donors","volume":"5","author":"Foudoulaki\u2010Paparizos L","year":"2002","journal-title":"Haema"},{"key":"e_1_2_8_27_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.21307\/immunohematology-2019-686","article-title":"A comprehensive IgA service provided by a blood transfusion center","volume":"14","author":"Munks R","year":"1998","journal-title":"Immunohematology"},{"key":"e_1_2_8_28_2","first-page":"887","article-title":"An enzyme\u2010linked immunosorbent assay to screen blood donors for IgA deficiency","volume":"84","author":"Sanz C","year":"1999","journal-title":"Haematologica"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1995.tb00214.x"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1986.tb04851.x"},{"key":"e_1_2_8_31_2","first-page":"653","article-title":"Low prevalence of IgA deficiency in north Indian population","volume":"123","author":"Chandran S","year":"2006","journal-title":"Indian J Med Res"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1973.tb00357.x"},{"key":"e_1_2_8_33_2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood.V34.5.573.573","article-title":"Serological specificity of human IgA and its significance in transfusion","volume":"34","author":"Vyas GN","year":"1969","journal-title":"Blood"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.1972.tb00032.x"},{"key":"e_1_2_8_35_2","first-page":"141","article-title":"Anti\u2010IgA\u2010mediated transfusion reactions in Canada","volume":"130","author":"Laschinger C","year":"1984","journal-title":"Can Med Assoc J"},{"key":"e_1_2_8_36_2","first-page":"25","article-title":"Blood components and transfusion reactions","volume":"2","author":"Kasprisin DO","year":"1981","journal-title":"Plasma Ther Transfus Technol"},{"key":"e_1_2_8_37_2","first-page":"259","article-title":"Serological investigations of 1358 transfusion reactions in 74,000 transfusions","volume":"15","author":"Ahrons S","year":"1968","journal-title":"Dan Med Bull"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.1962.tb00187.x"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2003.00662.x"},{"key":"e_1_2_8_40_2","article-title":"Allergic transfusion reactions from blood products donated by IgA\u2010deficient donors with and without anti\u2010IgA","volume":"47","author":"Robitaille N","year":"2007","journal-title":"Transfusion"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2010.02588.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2010.02588.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T07:59:42Z","timestamp":1697270382000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2010.02588.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1111\/j.1537-2995.2010.02588.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2010.02588.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}